FDA recalls over 200,000 duloxetine bottles due to N-nitroso-duloxetine contamination, increasing cancer risk.

Although it can start at any age, knee pain becomes more of an issue as we get older. As we age, the tissues become less pliable, brittle, weaker, and more prone to injury.

Nerve pain — a side effect of HIV medications and the infection itself — can be treated with duloxetine (Cymbalta), a common antidepressant. This offers a great benefit to people infected with HIV, as ...

Providers also prescribe SNRIs — such as venlafaxine (Effexor) and duloxetine (Cymbalta ... sensitive points of the skin to relieve pain and muscle tension. For PTSD, a trained EFT mental ...

In this study, escitalopram treatment resulted in significantly greater improvement compared with duloxetine on the prospectively defined primary efficacy endpoint of change from baseline in MADRS ...

Fact checked by Nick Blackmer Over 200,000 bottles of the antidepressant duloxetine have been recalled due to ...

Pain in the arch of the foot is a common problem, especially among athletes. Possible causes include plantar fasciitis, direct injury and structural issues. Treatments can include resting ...

Arsenal are aiming to book a place in the semi-final of the Carabao Cup when they face Crystal Palace this evening. The Gunners host the Eagles at the Emirates Stadium in the quarter-final of the ...

The FDA reports that the recall was initiatiated after it was discovered that the products contained elevated levels of N-nitroso-duloxetine (NDXT), which has been identified as potentially ...

Pain or soreness in the shoulders represents our ability to carry our experiences in our life joyously or that we make life a burden by our attitude. Medical Intuitive Archanaa Shyam explains ...

Cleveland Browns DE Myles Garrett suffered a curious injury around his face against the Kansas City Chiefs Sunday. While trying to get by Chiefs’ tackle Joe Thuney, Garrett suddenly whipped back, ...

The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second ...